Lepore, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 1.416
EU - Europa 1.309
AS - Asia 1.006
SA - Sud America 253
AF - Africa 17
OC - Oceania 1
Totale 4.002
Nazione #
US - Stati Uniti d'America 1.375
DE - Germania 502
SG - Singapore 466
CN - Cina 262
BR - Brasile 211
SE - Svezia 198
IT - Italia 118
FR - Francia 101
UA - Ucraina 92
GB - Regno Unito 75
VN - Vietnam 57
FI - Finlandia 55
IE - Irlanda 48
IN - India 48
ID - Indonesia 37
HK - Hong Kong 25
RU - Federazione Russa 24
AR - Argentina 20
BE - Belgio 18
PL - Polonia 18
MX - Messico 17
BD - Bangladesh 16
JP - Giappone 16
CA - Canada 15
TR - Turchia 15
ES - Italia 12
IR - Iran 12
IQ - Iraq 11
KR - Corea 10
NL - Olanda 9
CO - Colombia 7
CZ - Repubblica Ceca 7
PH - Filippine 7
ZA - Sudafrica 7
AT - Austria 6
TW - Taiwan 6
PT - Portogallo 5
EC - Ecuador 4
GR - Grecia 4
LT - Lituania 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CH - Svizzera 3
CL - Cile 3
JM - Giamaica 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
KE - Kenya 2
KG - Kirghizistan 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
TN - Tunisia 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HN - Honduras 1
KW - Kuwait 1
LU - Lussemburgo 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.002
Città #
Chandler 267
Singapore 192
Ashburn 116
Los Angeles 66
Ann Arbor 56
Jacksonville 55
Beijing 54
New York 49
San Mateo 49
Dublin 45
Hefei 40
Marseille 39
Milan 31
Jakarta 30
Munich 29
Nanjing 29
Helsinki 28
Boston 27
Hong Kong 24
Dallas 23
Wilmington 22
Nanchang 21
Princeton 20
Woodbridge 20
Dearborn 19
Cattolica 18
Rome 18
Brussels 17
Ho Chi Minh City 17
Houston 17
Nürnberg 17
São Paulo 16
The Dalles 16
Moscow 15
Redmond 14
Tokyo 14
Augusta 13
Hanoi 13
Fairfield 12
Seattle 12
Pune 11
Dhaka 10
Frankfurt am Main 10
Kent 10
Seoul 10
Warsaw 10
Lancaster 9
Lawrence 9
Andover 8
Atlanta 8
Brooklyn 8
Izmir 8
Buffalo 7
Düsseldorf 7
Mexico City 7
Santa Clara 7
Bremen 6
Detroit 6
Hebei 6
Leawood 6
London 6
Montreal 6
Poplar 6
Redwood City 6
Taichung 6
Turku 6
Boardman 5
Brno 5
Denver 5
Hangzhou 5
Kish 5
Lappeenranta 5
Manchester 5
Shenyang 5
University Park 5
Amsterdam 4
Bogotá 4
Busto Arsizio 4
Chennai 4
Fremont 4
Kunming 4
Madrid 4
Orem 4
Paris 4
Pescara 4
Rio de Janeiro 4
Roubaix 4
San Francisco 4
Tashkent 4
Tianjin 4
Vienna 4
Wroclaw 4
Baghdad 3
Belo Horizonte 3
Bexley 3
Changchun 3
Changsha 3
Da Nang 3
Fuzhou 3
Isidro Casanova 3
Totale 1.916
Nome #
Cortical visual function in preterm infants in the first year. 260
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings 203
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 200
Effectiveness of Ketorolac Tromethamine in Prevention of Severe Retinopathy of Prematurity. 187
Occipital porencephaly in a child with gyrate atrophy of the choroid and retina. 178
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 178
An epidemiological analysis of retinopathy of prematurity over 10 years. 148
Chronic taaurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats 142
Early visual and neuro-development in preterm infants with and without retinopathy 135
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings 134
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia 130
A cost effectiveness analysis of cataract surgery 121
Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity 120
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: Incidence, presentation, and management of complications during general anesthesia 116
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 113
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 112
Functional and morphologic findings at four years after intravitreal bevacizumab or laser for type 1 ROP 97
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 95
Transfusion-Free Survival Predicts Severe Retinopathy in Preterm Neonates. 95
Convolutional neural network based on fluorescein angiography images for retinopathy of prematurity management 88
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 87
The role of retinal imaging in the management of abusive head trauma cases 86
Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal Implications 83
Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab 76
Effect of topical antiinflammatory drugs on mechanical behavior of rabbit cornea 67
Bilateral fixed mydriasis reversible during orthopedic surgery in the prone position 66
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial 59
Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial 56
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226) REPLY 55
Re: Yu et al.: Releasable encircling band for primary rhegmatogenous retinal detachment (Ophthalmology 2014;121:2504-5) 55
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next 53
Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9) Reply 49
International Classification of Retinopathy of Prematurity, Third Edition 47
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial 47
Early angiographic signs of retinopathy of prematurity requiring treatment 46
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial 46
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study 42
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial 39
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial 39
P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of Prematurity 39
Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis 36
Ranibizumab population pharmacokinetics and free vegf pharmacodynamics in preterm infants with retinopathy of prematurity in the rainbow trial 31
Totale 4.056
Categoria #
all - tutte 16.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021144 0 0 0 0 0 10 25 8 32 12 51 6
2021/2022265 25 20 2 12 10 5 3 59 16 14 33 66
2022/2023706 83 123 64 87 49 80 51 50 85 9 17 8
2023/2024289 20 75 23 11 5 57 14 3 5 19 36 21
2024/2025695 13 18 56 23 38 28 35 26 126 63 143 126
2025/20261.003 284 73 122 224 273 27 0 0 0 0 0 0
Totale 4.056